Both in null
GSK vs State Street SPDR S&P 500 ETF Trust
Over the past year GSK returned +20.1% and SPY returned +15.1%; their daily moves had a correlation of 0.12.
GSK +20.1% SPY +15.1%Growth of $1, one year, split-adjusted
| Metric | GSK | SPY |
|---|---|---|
| Price | $49.35 | $764.20 |
| Market cap | $98.87B | $815.23B |
| Today | −0.70% | −0.18% |
| 1 month | −2.9% | −0.7% |
| 6 months | −9.0% | +20.9% |
| Year to date | +0.6% | +12.1% |
| 1 year | +23.8% | +15.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$26.49B | — |
| Dividend yield | 3.66% | 0.99% |
| Volatility (60d) | 24.5% | 11.1% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).